Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Marchex (NASDAQ:MCHX) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:20 PM. Here's what investors need to know about the announcement. Earnings Marchex beat estimated earnings by 50.0%, reporting an EPS of $-0.01 versus an estimate of $-0.02.

Benzinga

Recap: Fiesta Restaurant Gr Q1 Earnings

Fiesta Restaurant Gr (NASDAQ:FRGI) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga

Recap: PDF Solutions Q1 Earnings

PDF Solutions (NASDAQ:PDFS) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings PDF Solutions beat estimated earnings by 50.0%, reporting an EPS of $0.09 versus an estimate of $0.06.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Spectrum Pharmaceuticals: Q1 Earnings Insights

Spectrum Pharmaceuticals (NASDAQ:SPPI) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga

Regulus Therapeutics: Q1 Earnings Insights

Regulus Therapeutics (NASDAQ:RGLS) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Regulus Therapeutics reported in-line EPS of $-0.05 versus an estimate of $-0.05.

Benzinga

Digimarc: Q1 Earnings Insights

Digimarc (NASDAQ:DMRC) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Digimarc missed estimated earnings by 4.55%, reporting an EPS of $-0.69 versus an estimate of $-0.66.

Benzinga

Analyst Ratings for Integral Ad Science

Integral Ad Science (NASDAQ:IAS) has observed the following analyst ratings within the last quarter:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Expert Ratings for GrowGeneration

GrowGeneration (NASDAQ:GRWG) has observed the following analyst ratings within the last quarter:

Benzinga

What 21 Analyst Ratings Have To Say About Rivian Automotive

Over the past 3 months, 21 analysts have published their opinion on Rivian Automotive (NASDAQ:RIVN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Analyst Ratings for Nexstar Media Group

Analysts have provided the following ratings for Nexstar Media Group (NASDAQ:NXST) within the last quarter:

Benzinga

How Is The Market Feeling About Western Digital?

Western Digital's (NASDAQ:WDC) short percent of float has risen 16.89% since its last report. The company recently reported that it has 7.82 million shares sold short, which is 2.56% of all regular shares that are available for trading.

Benzinga

Expert Ratings for Alignment Healthcare

Analysts have provided the following ratings for Alignment Healthcare (NASDAQ:ALHC) within the last quarter:

Benzinga

Expert Ratings for Zai Lab

Analysts have provided the following ratings for Zai Lab (NASDAQ:ZLAB) within the last quarter:

Benzinga

Analyzing Hertz Global Holdings's Short Interest

Hertz Global Holdings's (NASDAQ:HTZ) short percent of float has fallen 5.0% since its last report. The company recently reported that it has 16.87 million shares sold short, which is 12.17% of all regular shares that are available for trading.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Analyzing Blink Charging's Short Interest

Blink Charging's (NASDAQ:BLNK) short percent of float has fallen 6.43% since its last report. The company recently reported that it has 10.64 million shares sold short, which is 29.09% of all regular shares that are available for trading.

Benzinga

Affirm Stock Soars Afterhours On Solid Q3 Results

Affirm Holdings Inc (NASDAQ: AFRM) reported third-quarter r

Benzinga

If You Invested $1,000 In The Coinbase IPO, Here's How Much You'd Have Now

Cryptocurrency platform Coinbase Global Inc (NASDAQ: COIN) had one of the biggest public listings of all time when it went public via direct listing in April 2021. Here’s a look back at how shares have done since the Coinbase IPO.

Benzinga

Markets Pare Intraday Losses, Still Finish Marginally Lower

U.S. indices traded lower Thursday as stocks experienced continued volatility amid concerns over rising interest rates and inflation.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Raymond James Sees 'Pipeline Key Success Factor' For This MedTech Stock

Raymond James has reiterated Outperform rating on LumiraDx Limited's (NASDAQ:LMDX) shares after 1Q revenue beat but lower than expected margins that ultimately do very little to impact long-term views of the company. They lowered the price target from $9 to $7. Revenues were 7% above Raymond James' view and 12% above consensus. The beat was…

Benzinga

Affirm Surges Heading Into Q3 Earnings: How To Play The Stock

Affirm Holdings, Inc (NASDAQ: AFRM) is set to print its fiscal third-quarter financial results after the market closes on Thursday. The stock was trading more than 20% higher heading into the event.

Benzinga

Alphabet Stock Hits 52-Week Low: What's Going On?

Alphabet Inc (NASDAQ: GOOGL) (NASDAQ: GOOG) shares are trading lower Thursday and have fallen nearly 6% over the last week.

Benzinga

Read Why HC Wainwright Lowered Price Target On This Small Biotech Stock

U.S. marketing application filing for Cidara Therapeutics Inc's (NASDAQ: CDTX) rezafungin remains on track for mid-2022, setting up a potential early 2023 approval and launch.

Benzinga

Which Chinese Firms Face Delisting From US Stock Exchanges?

Geopolitical tensions between China and the US have escalated in recent years amid efforts by both countries to become the world’s economic powerhouse.

Benzinga

HC Wainwright Says This Stock Is Well Capitalized For Value Realization Of Pipeline, Despite COVID-19 Uncertainty

Given the uncertainty, HC Wainwright moderated its COVID-19 franchise estimates, the primary driver of estimate reductions, and price target reduction to $125 (from $200) on Vir Biotechnology Inc (NASDAQ:VIR). The analyst maintained a Buy rating on VIR shares. The analyst continues to view Vir's platform, validated with successful antiviral therapies against Ebola and COVID-19, and pipeline,…

Benzinga

Mid-Afternoon Market Update: Nasdaq Down 200 Points; Dutch Bros Shares Plunge

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 200 points on Thursday.

1 … 539 540 541 542

People

Donald Trump

196,940 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.